Journal introduction: Emerging Microbes & Infections

dearhang

本帖最后由 细菌耐药 于 2017-2-8 03:14 编辑

Emerging Microbes & Infections (EMI) is a new open access, fully peer-reviewed international journal. The purpose of EMI is to provide a forum to publish a wide range of scientific reports related to emerging infectious diseases, especially with new information from developing countries where such diseases are constantly arising and being discovered regularly. It will report discoveries of emerging microbes (bacteria, viruses, fungi and other pathogens) including their previously unknown phenotypic or genotypic characteristics, as well as cutting edge information associated with microbial mechanisms of pathogenesis, immune evasion and protection, clinical presentation and outcome, drug efficacy and its resistance, epidemiology and other issues important to global health.EMI received an Impact Factor of 4.012*.
*2015 Journal Citation Reports® (Thomson Reuters, 2016)



Journal


上一篇:English Learning for Infection Control下一篇:Do you apply NSFC this year?













登录/注册后可看大图

细菌耐药

EMI SPECIAL TOPICS

EMI Special Topics are designed to bring together manuscripts published under similar scientific themes, such as TB, hepatitis, drug resistance, or EV71. Each Special Topic is organized under the supervision of 1-2 Guest Editors who is an active investigator in the specific area of interest.

EMI Special Topics provide a unique forum to publish and compile manuscripts that address key research questions from an important area of emerging infectious diseases. Both historical and current results and opinion will be included so that authors and readers can achieve a better understanding of the key issues. At the same time, we hope that this forum will inspire further research, leading to more published results in this continuously growing space.

细菌耐药

ZIKA
Guest Editors: Kwok-yung Yuen (Department of Microbiology, The University of Hong Kong, Hong Kong, China) and Shan Lu (Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA).
Zika, which was first isolated from the serum of a febrile sentinel rhesus macaque in 1947 in Zika Forest of Uganda, is emerging as a major ongoing pandemic worldwide in the last few years. Zika virus is a single-stranded ribonucleic acid (RNA) virus mainly transmitted by mosquitoes. EMI has published a growing list of novel research reports related to different aspects of Zika epidemics and a special topic in this area is established to facilitate the easy access by global researchers.

EBOLA
Guest Editors: Hans-Dieter Klenk (Institut für Virologie, Philipps-Universität, Marburg, Germany) and Shan Lu (Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA)
Emerging Microbes & Infections (EMI) is proud to present the special topic- Ebola, which covers a wide range of research questions including drug discovery, passive immune therapy and vaccine development, leading to the effective control of this deadly virus.

EV71- a major emerging threat to children in Asia
Guest Editor: Ralf Altmeyer (Institut Pasteur Shanghai) and Shan Lu (U Mass Medical School)
This EMI Special Topic on EV71 includes papers on the characterization of EV71, a potentially highly virulent emerging viral infection targeting the pediatric population.

Drug Resistance and Novel Antimicrobial Agents
Guest Editor: Ying Zhang (Johns Hopkins University, USA)
In this Special Topic we provide papers on antimicrobial resistance in all medically relevant bacteria, viruses, parasites and fungi including epidemiology and surveillance of resistant microbes, mechanisms of action and resistance, detection of resistance, treatment practice and strategies, and new drug development.

Tuberculosis (TB)- what is new
Guest Editors: QianGao (Shanghai Medical College, Fudan University, China) and Wenhong Zhang (Huashan Hospital, China)
The EMI Special Topic on TB incorporates research reports and high quality reviews on the following areas of TB research: epidemiology, fundamental research, development of new diagnostics and biomarkers, development of new drugs and vaccines, and public health issues related to this important pathogen.

Hepatitis- updates from the classical emerging infections
Guest Editor: Shuping Tong (Brown University, USA) and Xinxin Zhang (Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai)
Hepatitis viruses (HAV, HBV, HCV, HDV, HEV) belong to diverse virus families and are transmitted by different routes. Some are enveloped and the genome can be single-stranded RNA or double-stranded DNA. Though HAV and HEV usually cause acute infections, chronic HEV infections have been observed recently. Various mechanisms for persistent infections by HBV or HCV, and their roles leading to liver cirrhosis and hepatocellular carcinoma have been further explored. Novel data on the molecular biology of hepatitis viruses, antiviral drugs, and new therapeutic targets have been presented regularly. EMI Special Topic - Viral Hepatitis will cover these hepatitis viruses in terms of biology, pathogenesis, immune response, therapy, and prevention, with special emphasis on recent progress.

Emerging seasonal and pandemic influenza infections
Guest Editor: Hongzhou Lu (Shanghai Public Health Clinic Center, Fudan University, Shanghai)
EMI Special Topic- emerging seasonal and pandemic influenza infections will include papers on the basic and clinical researches of emerging influenza viruses in recent years. Influenza was prevalent all over the world and can cause severe diseases in high-risk people. Avian influenza viruses can also infect human and cause deaths. The human infection caused by highly pathogenic avian influenza virus (H5N1) occurred initially in Hongkong in 1997. Human infection with avian influenza A(H7N9) was first reported from China in March 2013. The understanding of the pathogenesis, epidemiology, diagnosis and treatment of avian influenza virus infection has been enhanced. Extensive studies have been done on the seasonal influenza viruses especially influenza A(H1N1)pdm09. The H1N1 virus strain was first identified in 2009, caused the H1N1 influenza pandemic and is still circulating all over the world. EMI Special Topic-influenza welcomes research reports and high quality reviews on these important emerging viruses.

细菌耐药

Editors-in-Chief
Yu-Mei Wen

Editor
Yu-Mei Wen MD is founder and professor of Institute of Medical Microbiology, Fudan University, China and Professor of Key Laboratory of Medical Molecular Virology, Ministry of Education/Ministry of Health. Her research interests are in molecular virology and immunology of hepatitis B virus, and in microbial functional genomic studies. She is one of the pioneers in developing therapeutic vaccine for chronic hepatitis B patients. Prof. Wen graduated from Shanghai Medical University and has been a WHO fellow at London School of Hygiene and Tropical Medicine, and Fogarty visiting scholar at NIAID, National Institutes of Health, USA. She has published 240 articles home and abroad, and has edited and co-edited 8 books, including Viral Hepatitis in China-Problems and Control Strategies (Karger publisher, 1992) and recent works on micorbes and infections in China (World Scientific Publisher, 2010). She was acting editor of Archives of Virology (2008-2011) and has served as reviewer for PloS One, J Med Virology, Vaccine etc.

Hans-Dieter Klenk

Editor
Hans-Dieter Klenk received his M.D. from the University of Cologne in 1964 and a degree in biochemistry from the University of Tübingen in 1967. From 1967 to 1970 he was a postdoctoral fellow with Dr. P.W. Choppin at the Rockefeller University in New York. From 1970 to 1985 he held several positions at the Institute of Virology of the University of Giessen. From 1985 to 2007 he was Professor of Virology and Head of the Department of Virology of the University of Marburg where he is now Professor emeritus. His research has focused on the structure and function of enveloped viruses (influenza viruses, paramyxoviruses, filoviruses) with special emphasis on the role of viral glycoproteins and RNA polymerase in the infection process, in pathogenesis and in interspezies transmission. He is author of more than 400 scientific publications.

Shan Lu

Editor
Shan Lu, MD, PhD, MHA, is a physician scientist and a leader in novel vaccine research including vaccines against emerging infectious diseases. Currently he is professor of Medicine, Biochemistry and Molecular Pharmacology at the University of Massachusetts Medical School (UMMS), USA. He received his MD from the Nanjing Medical University and PhD from the University of Massachusetts Medical School. He was a Howard Hughes Physician Research Fellow. He holds an adjunct faculty appointment at Fudan University, China. He has been an Executive Board member for the International Society for Vaccines (ISV) and was ISV president during 2011-2013. Dr. Lu's research focuses on the induction of high quality and long lasting protective antibodies by novel vaccination strategies. He has published extensively on the candidate vaccines against a wide range of emerging infectious disease targets. His team developed the world's first polyvalent DNA prime-protein boost HIV-1 vaccine formulation which elicited broad and balanced immune responses in humans including cross-reactive neutralizing antibodies - a major progress in AIDS vaccine development. He has served as a member of various expert advisory boards for the US government, international organizations and private foundations.

Associate Editors
Babiuk, Lorne A. (University of Alberta, Edmonton)
García-Sastre, Adolfo (Mount Sinai School of Medicine, New York)
Tang, Yiwei (Memorial Sloan-Kettering Cancer Center, New York)
Xu, Jianguo        (Chinese Center for Disease Control and Prevention, Beijing)
Yuan, Zhenghong (Shanghai Medical College, Fudan University, Shanghai)
Yuen, Kwok-Yung (The University of Hong Kong, Hong Kong)
Zhang, Wenhong (Huashan Hospital, Fudan University, Shanghai)
Ishii, Ken J. (National Institute of Biomedical Innovation, Health and Nutrition (NIHIOHN), Osaka)
Review Editors        Study keywords
Jiang, Shibo        HIV-1; SARS
Jin, Dongyan        Oncogenic viruses; Virus-host interaction; Innate antiviral response; Coronaviruses
Lu, Shan        Vaccines; Antibodies
Strecker, Thomas        Arenaviruses; Filoviruses; Virus assembly; Virus-host interaction
Tang, Yiwei        Diagnostic medicine
Zhang, Jingren        Bacteria
Zhang, Ying        Tuberculosis; Drug resistance; Bacterial persistent infections
Zhou, Daoguo        Host-pathogen interactions; Bacterial invasion; Actin; Ubiquitin
Lee, Benhur        RNA viruses, Virus entry and assembly, Nuclear-cytoplasmic trafficking, Broad-spectrum antivirals
Editorial Board
Block, Timothy M. (Drexel University College of Medicine, Philadelphia)
Cao, Wuchun (Beijing Institute of Microbiology and Epidemiology, Beijing)
Chen, Pei-Jer (National Taiwan University College of Medicine, Taipei)
Chen, Xinwen (Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan)
Dong, Xiaoping (Chinese Center for Disease Control and Prevention, Beijing)
Drosten, Christian (University of Bonn Medical Centre, Bonn)
Hollinger, F. Blaine (Baylor College of Medicine, Houston)
Javid, Babak (Tsinghua University, Beijing)
Hsueh, Po-Ren (National Taiwan University College of Medicine, Taipei)
Jiang, Shibo (Shanghai Medical College, Fudan University, Shanghai)
Jin, Dongyan (The University of Hong Kong, Hong Kong)
Jin, Qi        (Chinese Academy Medical Sciences & Peking Union Medical College, Beijing)
Kan, Biao (Chinese Center for Disease Control and Prevention, Beijing)
Lachmann, Peter J. (University of Cambridge, Cambridge)
Lee, Benhur (Icahn School of Medicine at Mount Sinai, New York)
Lu, Mengji (University of Duisburg-Essen, Essen)
Lu, Hongzhou (Shanghai Medical College, Fudan University, Shanghai)
Pelegrin, Mireia (Institut de Génétique Moléculaire de Montpellier, Montpellier)
Qi, Zhongtian (Second Military Medical University, Shanghai)
Qian, Yuan (Capital Institute of Pediatrics, Beijing)
Qu, Di (Shanghai Medical College, Fudan University, Shanghai)
Revill, Peter Andrew (Victorian Infectious Diseases Reference Laboratory, Melborne)
Roggendorf, Michael        (Institute for Virology, Essen)
Shi, Yan (Tsinghua University, Beijing)
Shieh, Wun-Ju (Centers for Disease Control and Prevention, Atlanta)
Strecker, Thomas (Institut für Virologie der Philipps-Universität Marburg, Marburg)
Shu, Yuelong (Chinese Center for Disease Control and Prevention, Beijing)
Tong, Shuping (Shanghai Medical College, Fudan University, Shanghai)
Wang, Bin (Shanghai Medical College, Fudan University, Shanghai)
Wang, Hua (Jiangsu Center for Disease Control and Prevention, Nanjing)
Wu, Chao (Drum Tower Hospital, Nanjing)
Xu, Jianqing (Shanghai Medical Collge, Fudan University, Shanghai)
Yang, X. Frank (Indiana University School of Medcine, Indianapolis)
Zhang, Jingren (Tsinghua University, Beijing)
Zhang, Linqi (Tsinghua University, Beijing)
Zhang, Ying (Johns Hopkins University, Baltimore)
Zhong, Jin (Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai)
Zhou, Daoguo (Perdue University, West Lafayette)

细菌耐药

I think it is a good journal for us to submit our manuscript.

hbfyygb

谢谢老师的分享与推荐！

tianzhilan

谢谢老师的分享！！！

yanghongmei

谢谢“细菌耐药”老师的分享，继续加油学习英语，请问查找文献的途径是？

ICBC

Thomson Reuters 关于医疗、医药行业的的报道是非常值得一看的

郁闷中落寞

4分多呢